Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenPierre D. Delmas, Claus Christiansen, Nina H. Bjarnason et al.|New England Journal of Medicine|1997Cited by 1.6k
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisCharles H. Chesnut, Ralph C. Schimmer, Pierre D. Delmas et al.|Journal of Bone and Mineral Research|2004Cited by 1.2k
Incorporation and distribution of strontium in boneSvein G. Dahl, Claus Christiansen, Philippe Allain et al.|Bone|2001Cited by 582
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.J.J. Body, R.D. Rubens, Reiner Bartl et al.|Journal of Clinical Oncology|1998Cited by 366
Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide-Treated Postmenopausal Women With OsteoporosisPeiqi Chen, John H. Krege, Paul D. Miller et al.|Journal of Bone and Mineral Research|2006Cited by 157